Cholesterol treatment with statins: who is left out and who makes it to goal?
- PMID: 20236527
- PMCID: PMC2846927
- DOI: 10.1186/1472-6963-10-68
Cholesterol treatment with statins: who is left out and who makes it to goal?
Abstract
Background: Whether patient socio-demographic characteristics (age, sex, race/ethnicity, income, and education) are independently associated with failure to receive indicated statin therapy and/or to achieve low density lipoprotein cholesterol (LDL-C) therapy goals are not known. We examined socio-demographic factors associated with a) eligibility for statin therapy among those not on statins, and b) achievement of statin therapy goals.
Methods: Adults (21-79 years) participating in the United States (US) National Health and Nutrition Examination Surveys, 1999-2006 were studied. Statin eligibility and achievement of target LDL-C was assessed using the US Third Adult Treatment Panel (ATP III) on Treatment of High Cholesterol guidelines.
Results: Among 6,043 participants not taking statins, 10.4% were eligible. Adjusted predictors of statin eligibility among statin non-users were being older, male, poorer, and less educated. Hispanics were less likely to be eligible but not using statins, an effect that became non-significant with adjustment for language usually spoken at home. Among 537 persons taking statins, 81% were at LDL-C goal. Adjusted predictors of goal failure among statin users were being male and poorer. These risks were not attenuated by adjustment for healthcare access or utilization.
Conclusion: Among person's not taking statins, the socio-economically disadvantaged are more likely to be eligible and among those on statins, the socio-economically disadvantaged are less likely to achieve statin treatment goals. Further study is needed to identify specific amenable patient and/or physician factors that contribute to these disparities.
Figures
Similar articles
-
Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines.Ann Pharmacother. 2008 Sep;42(9):1208-15. doi: 10.1345/aph.1L181. Epub 2008 Jul 22. Ann Pharmacother. 2008. PMID: 18648016
-
Prevalence of the American College of Cardiology/American Heart Association statin eligibility groups, statin use, and low-density lipoprotein cholesterol control in US adults using the National Health and Nutrition Examination Survey 2011-2012.J Clin Lipidol. 2016 Sep-Oct;10(5):1109-18. doi: 10.1016/j.jacl.2016.06.011. Epub 2016 Jun 29. J Clin Lipidol. 2016. PMID: 27678427
-
Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.Am J Geriatr Pharmacother. 2007 Sep;5(3):185-94. doi: 10.1016/j.amjopharm.2007.10.002. Am J Geriatr Pharmacother. 2007. PMID: 17996658
-
Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.Curr Med Res Opin. 2006 Mar;22(3):511-28. doi: 10.1185/030079906X89856. Curr Med Res Opin. 2006. PMID: 16574035 Review.
-
Understanding practice patterns and low-density lipoprotein cholesterol goal attainment implications of switching patients from simvastatin in a health plan setting.Am J Manag Care. 2007 Dec;13 Suppl 10:S276-81. Am J Manag Care. 2007. PMID: 18095778 Review.
Cited by
-
Risk-enhancing factors and social determinants of health in risk assessment for atherosclerotic cardiovascular disease.PLoS One. 2024 Oct 25;19(10):e0312756. doi: 10.1371/journal.pone.0312756. eCollection 2024. PLoS One. 2024. PMID: 39453943 Free PMC article.
-
Statins Versus Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors- Are We Doing Better? A Systematic Review on Treatment Disparity.Cureus. 2020 Oct 15;12(10):e10965. doi: 10.7759/cureus.10965. Cureus. 2020. PMID: 33209524 Free PMC article. Review.
-
Beyond insurance coverage: usual source of care in the treatment of hypertension and hypercholesterolemia. Data from the 2003-2006 National Health and Nutrition Examination Survey.Am Heart J. 2010 Jul;160(1):115-21. doi: 10.1016/j.ahj.2010.04.013. Am Heart J. 2010. PMID: 20598981 Free PMC article.
-
Relationship between Statin Utilization and Socioeconomic Deprivation in Hungary.Front Pharmacol. 2016 Mar 24;7:66. doi: 10.3389/fphar.2016.00066. eCollection 2016. Front Pharmacol. 2016. PMID: 27047381 Free PMC article.
-
Cardiovascular care guideline implementation in community health centers in Oregon: a mixed-methods analysis of real-world barriers and challenges.BMC Health Serv Res. 2017 Apr 5;17(1):253. doi: 10.1186/s12913-017-2194-3. BMC Health Serv Res. 2017. PMID: 28381249 Free PMC article.
References
-
- The Henry J Kaiser Family Foundation. Ethnic differences in Cardiac Care: The Weight of the Evidence. Menlo Park, Henry J Kaiser Family Foundation; 2002.